Patient organizations

Patient organizations are important partners for EHA and we are delighted to collaborate with them in several areas. For a number of years patient organizations have organized a Patient Advocacy Session at EHA Annual Congress. In addition, EHA and patient organizations work together to advocate issues of common interest, such as personalized medicine or the regulations for clinical trials.

Twice a year, EHA is honored to invite patient organizations to meet and discuss current issues of common concern, to exchange information, and to develop joint projects. The patient organizations, with which EHA collaborates, are listed below. These organizations are European or international in scope. They are often umbrella organizations of national or disease-specific patient organizations. All of them represent patients with hematological diseases.

If you, or a loved one, suffer from a hematological disorder, then please contact the relevant patient organization below.

Patient organizations collaborating with EHA:

Cancer

European Cancer Patient Coalition (ECPC)

Chronic Myeloid Leukemia

CML Advocates Network

Hemochromatosis

European Federation of Associations of Patients with Haemochromatosis (EFAPH)

Hemophilia

European Haemophilia Consortium (EHC)

Immune Thrombocytopenia (formerly known as Idiopathic Thrombocytopenic Purpura ITP)

ITP Support Association

Lymphoma

Lymphoma Coalition (LC)

Myelodisplastic Syndromes

International MDS Alliance

Myeloma

Myeloma Patients Europe (MPE)

Thalassemia

Thalassaemia International Federation (TIF)

Waldenström's Macroglobulinemia

European Waldenströms Macroglobulinemia network (EWMnetwork)

Application procedure

European/international umbrella organizations, representing primarily patients with hematological diseases who are interested in collaborating with EHA, are welcome to contact us (communication@ehaweb.org). Please provide the following information: name of the organization, name of its representative/contact person, website address, scope and size of the organization.